Showing results (1-10 of 213) with videos related to
Sort By:
Pageof 22
Drug Design, Development and Therapy|April 8, 2015
A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in JapanTetsuya TanimotoJournal of Bone and Mineral Metabolism|November 23, 2022
Management of cancer pain due to bone metastasisDaisuke Takei, Keita TagamiJMA Journal|November 23, 2020
Severe Fever with Thrombocytopenia Syndrome: Japan under Threat from Life-threatening Emerging Tick-borne DiseaseAndy Crump, Tetsuya TanimotoGan to Kagaku Ryoho. Cancer & Chemotherapy|December 17, 2010
[A case of triple malignant tumors consisting of esophagus, stomach and malignant lymphoma with a histopathological feature of collision between gastric cancer and malignant lymphoma--a case report]Keita Tagami, Shigeru Tanda, Hiromi Tokumura, et al.Indian Journal of Palliative Care|December 14, 2020
Effectiveness of Gabapentinoids for Cancer-related Rectal and Vesical Tenesmus: Report of Four CasesKeita Tagami, Masaru Yoshizumi, Akira Inoue, et al.Case Reports in Nephrology and Dialysis|June 11, 2020
Cat Rearing: A Potential Risk of Fulminant Sepsis Caused by <i>Capnocytophaga canimorsus</i> in a Hemodialysis PatientJinichi Mori, Kumi Oshima, Tetsuya TanimotoInvestigational New Drugs|July 16, 2021
A critical appraisal of Japan's new drug approval process: a case study of FLT3-ITD inhibitor quizartinibKeisuke Kidoguch, Motoharu Shibusawa, Tetsuya TanimotoInternal Medicine (Tokyo, Japan)|July 31, 2020
Legionellosis in Japan: A Self-inflicted Wound?Tetsuya Tanimoto, Kenzo Takahashi, Andy CrumpInvestigational New Drugs|April 3, 2025
US FDA-accelerated approvals and subsequent withdrawals: influence on Japanese clinical oncology practice guidelinesHayase Hakariya, Akihiko Ozaki, Tetsuya TanimotoInvestigational New Drugs|March 9, 2018
A call for improved transparency in financial aspects of clinical trials: a case study of the CREATE-X trial in the New England Journal of MedicineAkihiko Ozaki, Morihito Takita, Tetsuya TanimotoPageof 22